Related Experiment Video
Updated: May 3, 2026

Cell Population Analyses During Skin Carcinogenesis
Published on: August 21, 2013
Keratinocyte-specific Smad2 ablation results in increased epithelial-mesenchymal transition during skin cancer
Kristina E Hoot1, Jessyka Lighthall, Gangwen Han
1Department of Cell and Developmental Biology, Oregon Health & Science University, Portland, Oregon 97239-2999, USA.
Abstract:
TGF-beta and its signaling mediators, Smad2, -3, and -4, are involved with tumor suppression and promotion functions. Smad4-/- mouse epidermis develops spontaneous skin squamous cell carcinomas (SCCs), and Smad3-/- mice are resistant to carcinogen-induced skin cancer; however, the role of Smad2 in skin carcinogenesis has not been explored. In the present study, we found that Smad2 and Smad4, but not Smad3, were frequently lost in human SCCs. Mice with keratinocyte-specific Smad2 deletion exhibited accelerated formation and malignant progression of chemically induced skin tumors compared with WT mice. Consistent with the loss of Smad2 in poorly differentiated human SCCs, Smad2-/- tumors were poorly differentiated and underwent epithelial-mesenchymal transition (EMT) prior to spontaneous Smad4 loss. Reduced E-cadherin and activation of its transcriptional repressor Snail were also found in Smad2-/- mouse epidermis and occurred more frequently in Smad2-negative human SCCs than in Smad2-positive SCCs. Knocking down Snail abrogated Smad2 loss-associated EMT, suggesting that Snail upregulation is a major mediator of Smad2 loss-associated EMT. Furthermore, Smad2 loss led to a significant increase in Smad4 binding to the Snail promoter, and knocking down either Smad3 or Smad4 in keratinocytes abrogated Smad2 loss-associated Snail overexpression. Our data suggest that enhanced Smad3/Smad4-mediated Snail transcription contributed to Smad2 loss-associated EMT during skin carcinogenesis.
Insights
Smad2 loss accelerates skin tumor development and promotes epithelial-mesenchymal transition (EMT) by upregulating Snail. Smad3 and Smad4 mediate this process, highlighting Smad2
Area of Science:
- Oncology
- Dermatology
- Molecular Biology
Background:
- Transforming growth factor-beta (TGF-β) signaling, involving Smad2, Smad3, and Smad4, plays a dual role in tumor suppression and promotion.
- While Smad4 deficiency leads to skin squamous cell carcinomas (SCCs) and Smad3 deficiency confers resistance to skin cancer, Smad2's role in skin carcinogenesis remains unclear.
Purpose of the Study:
- To investigate the role of Smad2 in skin carcinogenesis.
- To determine the molecular mechanisms by which Smad2 loss influences tumor progression and epithelial-mesenchymal transition (EMT).
Main Methods:
- Analysis of human SCCs for Smad2 and Smad4 loss.
- Generation of keratinocyte-specific Smad2-deficient mice.
- Chemical induction of skin tumors in wild-type (WT) and Smad2-deficient mice.
- Assessment of tumor differentiation, EMT markers (E-cadherin, Snail), and Smad binding to the Snail promoter.
Main Results:
- Smad2 and Smad4 were frequently lost in human SCCs; Smad2 loss accelerated chemically induced skin tumor formation and malignant progression in mice.
- Smad2-deficient tumors exhibited poor differentiation and EMT, characterized by reduced E-cadherin and increased Snail.
- Snail upregulation was identified as a key mediator of Smad2 loss-associated EMT, driven by enhanced Smad3/Smad4-mediated transcription of Snail.
Conclusions:
- Smad2 loss promotes skin carcinogenesis and EMT through Snail upregulation.
- Smad3 and Smad4 play a crucial role in mediating Smad2 loss-associated Snail overexpression and subsequent EMT.
- These findings elucidate a novel mechanism involving Smad2 in skin cancer development.
Related Concept Videos
Abnormal Proliferation
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
Renewal of Skin Epidermal Stem Cells
Clinical Applications of Epidermal Stem Cells
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Cellular Adaptation IV: Dysplasia and Metaplasia

